Replies to post #151077 on Elite Pharmaceuticals Inc (ELTP)

[Money_Tree]

First off the share structure is not close what it used to be so that $18 figure you're talking about with no products is not relatable. But to your point you do make a case why they mention puny estimates because 3 ADTs should get us well over $5-$6 even with this share structure. You then look at Pfizer and Purdue with constant problems regarding their ADTs and it should be a no brained Elite should get much higher than $1-$2, so idk why posters on here are so conservative, maybe they are just relating to what can happen in the next year.

[conix]

It is too simplistic to say that because a stock was at a particular high price in the past that because the company has more going for it the price should go higher.

You have to take into account how many shares were outstanding THEN and how many shares are outstanding there are NOW.

There is significantly more shares outstanding now.

Just keeping it real.

[dr_lowenstein]

I love all the talk about the good old days. when the stock traded over $18. so how about some facts, how many days in the history of elite did the stock trade $18 or over. 5 days, out of 3800 days it has traded. or .13% of the life history it traded over $18. For the past seven years, the average pps has been .13. By the way, does anyone know the pps on the day Mehta left and the beginning of the wonderful new regime took over?? I can tell you it was $2.01.
Oh, just on more FACT, back in the day, when it traded around 18 and 20, there was NO adt technology, read the 10k 6/29/01, only controlled release technology discussed not a single mention of ADT